Posted by Michael Wonder on 27 Nov 2018
NHS saves record £300 million by switching to cheaper arthritis drug
26 November 2018 - The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low-cost versions of the health service's most costly drug.
The saving - the biggest in NHS history from a single drug negotiation - could pay for 11,700 more community nurses or 19,800 more breast cancer treatments for patients.
The deal has come about through the introduction of "biosimilar" versions of adalimumab, which is prescribed to more than 46,000 patients for hospital-treated, serious conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.
